Please note that Interventional
Cardiology and Electrophysiology fellowships have been filled for the 2018-2019
The postgraduate program in cardiology at the University of Colorado Denver is designed to accommodate the needs of physicians whose goals include a career in academic cardiology with emphasis on teaching and research and who require strong training clinical cardiology.
Training Period: 3 years in General Cardiology with an option of a fourth year, if desired, for research in General Cardiology, Electrophysiology, Heart Failure or Interventional Cardiology
Training is received in the following areas:
• Adult cardiology including coronary care
• Cardiac electrophysiology and pacemaker therapy
• Cardiac catheterization including interventional cardiology
• Nuclear cardiology
• Exercise testing
• Cardiac transplantation
• Vascular medicine
• Cardiac MRI & CT
• Pulmonary Hypertension
• Preventive cardiology
• Cardiac rehabilitation
In addition, trainees will be familiarized with recent developments in cardiovascular physiology, biochemistry, pharmacology, and molecular biology. The philosophy behind the clinical training program is to provide both a thorough, comprehensive exposure to modern cardiology consultant practice, and sufficient scientific background to allow graduates of the program to critically evaluate future developments in this rapidly changing clinical specialty.
• University of Colorado Hospital at Anschutz Medical Campus
• Veterans Administration Medical Center
• Denver Health Medical Center
In addition, we have established an endowed fellowship in honor of Dr. S. Gilbert Blount, the first division head at the University of Colorado. This program allows one fellow per year to do clinical research as well as become involved in the teaching of cardiovascular medicine.
General Cardiology Fellowship Program
For many years, the Division of Cardiology has enjoyed a reputation for excellence in the training of clinical and academic cardiologists. The Division of Cardiology offers a comprehensive clinical and research environment. The training incorporates rotations and experiences at three large hospitals to insure a broad exposure to multiple cardiovascular disease states. The Advanced Heart Failure Treatment Program is international renown and offers trainees broad exposure to research opportunities, cardiac transplantation and ventricular assist devices. The program offers excellent experiences in acute cardiac care and cardiac catheterization. Our laboratories are equipped with the latest rotational and three dimensional imaging equipment and the University functions as the tertiary referral center for complex percutaneous interventions on valvular and congenital heart diseases. Our clinical electrophysiology program provides exposure to device management as well as complex ablation of atrial and ventricular fibrillation. The imaging facilities are fully equipped with Cardiac CT, MRI, and 3-D echocardiography. There are over 40 key clinical faculty members offering advanced training opportunities in interventional, electrophysiology , advanced heart failure, cardiac imaging and adult congenital. Trainees with interests in health services research will have the opportunity to receive a Masters or Ph.D. degree in Public Health through the School of Biometrics and Public Health at the University of Colorado Denver. The research fellows are supported by a NIH funding training grant.
Cardiovascular Disease Fellowship Training Program Application Instructions:
Thank you for your interest in the Cardiovascular Disease Fellowship Training Program at the University of Colorado School of Medicine. This Fellowship is a 3 year ACGME accredited program. We participate in the National Residency Matching Program (NRMP). Applications for fellowship starting on August 1, 2016 should be submitted through Electronic Residency Application Service (ERAS). Interviews are generally held on Mondays and Fridays during last two weeks of September and early October.
Please refer to the ERAS website for required documents and specific application details
Our Required documents include:
· Deans Letter
· USMLE Scores
· Personal statement of interest
· Three letters of recommendation. One should be from your residency program director.
All visa applications are welcomed and reviewed on a case by case basis.
Please note: Our deadline for receiving an application and support documents through ERAS is August 15, 2016.
We have five open slots for the Cardiovascular Disease Fellowship Training Program.
If you have any questions during the application process, please do not hesitate to contact Holly M. Ables, Education Office, at Holly.email@example.com
EP Fellowship Program
There is an active invasive cardiac electrophysiology laboratory staffed by Drs. Ryan Aleong, Duy Nguyen, William Sauer, and Paul Varosy. EP fellows are exposed to the clinical and educational endeavors of the Electrophysiology service in order to become competent to perform as an independent clinical electro physiologist. They become familiar with and competent in all aspects of the evaluation of patients with wide range of situations related to arrhythmias The general day to day activities includes attending a daily patient work rounds meeting to include the EP faculty, nursing staff and rotating cardiology fellow on service, to discuss the cases and patients for that day and the next. During the diagnostic portions of the study, all fellows are present in order to learn the techniques and decision-making tactics needed before proceeding with the appropriate intervention. Fellows have a continuous outpatient experience to include new outpatient consultations, patient follow-ups, and all types of defibrillator and pacemaker follow-ups. EP conferences are held daily. The conference schedule follows the written curriculum and reading list. Conferences are a mix of didactic topics given by the faculty as well as those prepared by the fellow. Quarterly the fellows meet with the program director to provide feedback and modifications of the curriculum.
Invasive and Interventional Cardiology Training
Activities in the cardiac catheterization laboratory at University of Colorado Hospital (UCH) headed by Dr. John Messenger include a full range of diagnostic and therapeutic coronary, peripheral and structural heart disease procedure performed in state-of-the-art laboratories with extensive computer assisted cardiac analysis systems. In addition, there is an active program in the pharmacologic therapy of patients with significant pulmonary hypertension, transplant cardiology, adult congenital heart disease. Dr. John Messenger, the director of the cardiac catheterization laboratory at UCH,and Dr. John Carroll, Director of Interventional Cardiology at UCH head the clinical programs in diagnostic and interventional cardiology. Peripheral interventional procedures are directed by Dr. Ivan Casserly. The general day to day activities include Pre-operative evaluation and preparation of the patients, screening and enrollment of patients in research protocols (assist research staff). Fellows are involved in all aspects of patient management in the cath lab including evaluation of patient data, performance of catheterization procedures, and post-procedure care and documentation. UCH sponsors an ACGME accredited training program in Interventional Cardiology that offers two positions per year. This program is a joint program at UCH and the Denver VA Medical Center.
Heart Failure Fellowship Program
The advanced heart failure program at the University of Colorado is headed by Dr. Andreas Brieke. It is the only program in the state and provides services to the entire Rocky Mountain region. The fellowship is designed to complete the ABIM requirements for board certification in this subspecialty. There are 9 key clinical faculty members with extensive experience in the medical management of advanced heart failure, ventricular assist devices, and transplantation. There is broad exposure to cardiac imaging, endomyocardial biopsy, metabolic exercise testing and genetics. Scholarly activity is an expectation and both research and basic science opportunities are available. The institution has laboratories conducting research on:
•Adrenergic signaling in heart failure
•Sarcomere dynamics and Contractile Proteins
•Gene programming in Hypertrophy and failure
•Cytokines and Cardiac Fibrosis
•Pulmonary Hypertension, Angiogenesis
•Diabetes and Metabolic syndromes
•Cardiac Metabolism and RV function
Board certification or eligibility in cardiology is a requirement for program entry.
Advanced Training in Adult Congenital Heart Disease
Children’s Hospital Colorado and University of Colorado Hospital, in conjunction with the University of Colorado School of Medicine, is pleased to offer a funded position for an ACGME accredited 24-month training program dedicated to the care of Adults with Congenital Heart disease.
We are looking for well qualified candidates who have completed a fellowship in pediatric cardiology or adult cardiology at an ACGME-accredited program and will be board eligible by the start of the 4th year.
The number of patients surviving to adulthood with congenital heart disease continues to increase, and as such our adult congenital heart disease program, first established in 2003, continues to grow, with over 2,000 outpatient visits per year. Our program is integrated between both Children’s Hospital Colorado and The University of Colorado Hospital, with training tailored to the trainee’s previous background. Successful graduates from our program will be board eligible for the ABIM Adult Congenital Heart disease board certification.
Fourth year applications will require the following:
• An updated curriculum vitae
• at least three letters of reference
• a personal statement highlighting why you wish to pursue Advanced training in the care of adults with congenital heart disease (or the ACHD Specialty Application
filled out in lieu of the letter of intent).
If you are not a USA citizen, include a copy of your ECFMG.
It is your responsibility to ensure all required information has been received.
All applications should be submitted by Aug 31.